Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas

NCT00002965 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

M.D. Anderson Cancer Center

Collaborators